These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 30970431)

  • 21. Relationship between the dynamics of non-alcoholic fatty liver disease and incident diabetes mellitus.
    Han JE; Shin HB; Ahn YH; Cho HJ; Cheong JY; Park B; Kim SS
    Sci Rep; 2022 Feb; 12(1):2538. PubMed ID: 35169195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non alcoholic fatty liver disease and risk of incident diabetes in subjects who are not obese.
    Sung KC; Seo DC; Lee SJ; Lee MY; Wild SH; Byrne CD
    Nutr Metab Cardiovasc Dis; 2019 May; 29(5):489-495. PubMed ID: 30940491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in Fatty Liver Disease and Incident Diabetes Mellitus in Young Korean Adults.
    Park KY; Hwang HS; Han K; Park HK
    Am J Prev Med; 2024 Apr; 66(4):717-724. PubMed ID: 38008134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between nonalcoholic fatty liver disease and incident diabetes mellitus among Japanese: a retrospective cohort study using propensity score matching.
    Zheng X; Cao C; He Y; Wang X; Wu J; Hu H
    Lipids Health Dis; 2021 Jun; 20(1):59. PubMed ID: 34130693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonalcoholic fatty liver disease in patients with type 2 diabetes.
    Younossi ZM; Gramlich T; Matteoni CA; Boparai N; McCullough AJ
    Clin Gastroenterol Hepatol; 2004 Mar; 2(3):262-5. PubMed ID: 15017611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Age-Related Decrease in Skeletal Muscle Mass Is an Independent Risk Factor for Incident Nonalcoholic Fatty Liver Disease: A 10-Year Retrospective Cohort Study.
    Lee MJ; Kim EH; Bae SJ; Kim GA; Park SW; Choe J; Jung CH; Lee WJ; Kim HK
    Gut Liver; 2019 Jan; 13(1):67-76. PubMed ID: 30037166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The interaction of nonalcoholic fatty liver disease and smoking on mortality among adults in the United States.
    Wijarnpreecha K; Scribani M; Kim D; Kim WR
    Liver Int; 2019 Jul; 39(7):1202-1206. PubMed ID: 30697898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Independent Association Between Improvement of Nonalcoholic Fatty Liver Disease and Reduced Incidence of Type 2 Diabetes.
    Yamazaki H; Tsuboya T; Tsuji K; Dohke M; Maguchi H
    Diabetes Care; 2015 Sep; 38(9):1673-9. PubMed ID: 26156527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between ultrasound features of nonalcoholic fatty liver disease and cardiometabolic risk factors in patients with newly diagnosed type 2 diabetes.
    Kosmalski M; Kasznicki J; Drzewoski J
    Pol Arch Med Wewn; 2013; 123(9):436-42. PubMed ID: 23792440
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolically Healthy Obesity and the Development of Nonalcoholic Fatty Liver Disease.
    Chang Y; Jung HS; Cho J; Zhang Y; Yun KE; Lazo M; Pastor-Barriuso R; Ahn J; Kim CW; Rampal S; Cainzos-Achirica M; Zhao D; Chung EC; Shin H; Guallar E; Ryu S
    Am J Gastroenterol; 2016 Aug; 111(8):1133-40. PubMed ID: 27185080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of longitudinal changes of body fat on the incidence and regression of nonalcoholic fatty liver disease.
    Kim D; Chung GE; Kwak MS; Kim YJ; Yoon JH
    Dig Liver Dis; 2018 Apr; 50(4):389-395. PubMed ID: 29373238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fatty liver index vs waist circumference for predicting non-alcoholic fatty liver disease.
    Motamed N; Sohrabi M; Ajdarkosh H; Hemmasi G; Maadi M; Sayeedian FS; Pirzad R; Abedi K; Aghapour S; Fallahnezhad M; Zamani F
    World J Gastroenterol; 2016 Mar; 22(10):3023-30. PubMed ID: 26973398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis.
    Ballestri S; Zona S; Targher G; Romagnoli D; Baldelli E; Nascimbeni F; Roverato A; Guaraldi G; Lonardo A
    J Gastroenterol Hepatol; 2016 May; 31(5):936-44. PubMed ID: 26667191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of new fatty liver, or resolution of existing fatty liver, over five years of follow-up, and risk of incident hypertension.
    Sung KC; Wild SH; Byrne CD
    J Hepatol; 2014 May; 60(5):1040-5. PubMed ID: 24445219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The persistence of fatty liver has a differential impact on the development of diabetes: The Kangbuk Samsung Health Study.
    Bae JC; Han JM; Cho JH; Kwon H; Park SE; Park CY; Lee WY; Oh KW; Kwon S; Park SW; Rhee EJ
    Diabetes Res Clin Pract; 2018 Jan; 135():1-6. PubMed ID: 29111276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nonalcoholic Fatty Liver Disease and the Development of Metabolic Comorbid Conditions in Patients With Human Immunodeficiency Virus Infection.
    Krahn T; Martel M; Sapir-Pichhadze R; Kronfli N; Falutz J; Guaraldi G; Lebouche B; Klein MB; Wong P; Deschenes M; Ghali P; Sebastiani G
    J Infect Dis; 2020 Aug; 222(5):787-797. PubMed ID: 32249283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aromatase Inhibitors and Newly Developed Nonalcoholic Fatty Liver Disease in Postmenopausal Patients with Early Breast Cancer: A Propensity Score-Matched Cohort Study.
    Lee JI; Yu JH; Anh SG; Lee HW; Jeong J; Lee KS
    Oncologist; 2019 Aug; 24(8):e653-e661. PubMed ID: 30679317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonalcoholic Fatty Liver Disease in Inflammatory Bowel Disease: Prevalence and Risk Factors.
    Principi M; Iannone A; Losurdo G; Mangia M; Shahini E; Albano F; Rizzi SF; La Fortezza RF; Lovero R; Contaldo A; Barone M; Leandro G; Ierardi E; Di Leo A
    Inflamm Bowel Dis; 2018 Jun; 24(7):1589-1596. PubMed ID: 29688336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nonalcoholic fatty liver disease is an early predictor of metabolic diseases in a metabolically healthy population.
    Yang S; Kwak S; Lee JH; Kang S; Lee SP
    PLoS One; 2019; 14(11):e0224626. PubMed ID: 31682638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Short sleep duration is a risk of incident nonalcoholic fatty liver disease: a population-based longitudinal study.
    Okamura T; Hashimoto Y; Hamaguchi M; Obora A; Kojima T; Fukui M
    J Gastrointestin Liver Dis; 2019 Mar; 28(1):73-81. PubMed ID: 30851175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.